Summary:
CNS Network is conducting a research study to evaluate the efficacy of flexibly-dosed dasotraline compared with placebo in adults with moderate to severe Binge Eating Disorder (BED).
Qualified Participants Must:
• Be between 18 and 55 years of age
•
Meet binge eating criteria (6 month duration)
•
Have a BMI of 18 – 45
•
Not have had Major depressive disorder in past 6 months
•
Not have substance abuse history in past 12 months
Qualified Participants May Receive:
Study-related medical care and investigational medication at no cost and may be compensated for time and travel.